212 related articles for article (PubMed ID: 27879212)
1. Generation of a gene-corrected isogenic control cell line from an Alzheimer's disease patient iPSC line carrying a A79V mutation in PSEN1.
Pires C; Schmid B; Petræus C; Poon A; Nimsanor N; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Hyttel P; Freude KK
Stem Cell Res; 2016 Sep; 17(2):285-288. PubMed ID: 27879212
[TBL] [Abstract][Full Text] [Related]
2. Generation of a gene-corrected isogenic control hiPSC line derived from a familial Alzheimer's disease patient carrying a L150P mutation in presenilin 1.
Poon A; Schmid B; Pires C; Nielsen TT; Hjermind LE; Nielsen JE; Holst B; Hyttel P; Freude KK
Stem Cell Res; 2016 Nov; 17(3):466-469. PubMed ID: 27789395
[TBL] [Abstract][Full Text] [Related]
3. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1.
Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Hyttel P; Freude KK
Stem Cell Res; 2016 Mar; 16(2):229-32. PubMed ID: 27345973
[TBL] [Abstract][Full Text] [Related]
4. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a M146I mutation in PSEN1.
Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Holst B; Hyttel P; Freude KK
Stem Cell Res; 2016 Mar; 16(2):334-7. PubMed ID: 27345998
[TBL] [Abstract][Full Text] [Related]
5. Derivation of induced pluripotent stem cells from a familial Alzheimer's disease patient carrying the L282F mutation in presenilin 1.
Poon A; Li T; Pires C; Nielsen TT; Nielsen JE; Holst B; Dinnyes A; Hyttel P; Freude KK
Stem Cell Res; 2016 Nov; 17(3):470-473. PubMed ID: 27789396
[TBL] [Abstract][Full Text] [Related]
6. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a L150P mutation in PSEN-1.
Tubsuwan A; Pires C; Rasmussen MA; Schmid B; Nielsen JE; Hjermind LE; Hall V; Nielsen TT; Waldemar G; Hyttel P; Clausen C; Kitiyanant N; Freude KK; Holst B
Stem Cell Res; 2016 Jan; 16(1):110-2. PubMed ID: 27345792
[TBL] [Abstract][Full Text] [Related]
7. Generation of two isogenic iPSC lines with either a heterozygous or a homozygous E280A mutation in the PSEN1 gene.
Frederiksen HR; Holst B; Mau-Holzmann UA; Freude K; Schmid B
Stem Cell Res; 2019 Mar; 35():101403. PubMed ID: 30769329
[TBL] [Abstract][Full Text] [Related]
8. Establishment of induced pluripotent stem cell line (ZZUi009-A) from an Alzheimer's disease patient carrying a PSEN1 gene mutation.
Wang Y; Jing N; Su L; Shi C; Zhang P; Wang Z; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
Stem Cell Res; 2018 Mar; 27():30-33. PubMed ID: 29304399
[TBL] [Abstract][Full Text] [Related]
9. Generation of a human induced pluripotent stem cell (iPSC) line from a patient with family history of diabetes carrying a C18R mutation in the PDX1 gene.
Wang X; Chen S; Burtscher I; Sterr M; Hieronimus A; Machicao F; Staiger H; Häring HU; Lederer G; Meitinger T; Lickert H
Stem Cell Res; 2016 Sep; 17(2):292-295. PubMed ID: 27879214
[TBL] [Abstract][Full Text] [Related]
10. Generation of an isogenic, gene-corrected iPSC line from a symptomatic 59-year-old female patient with frontotemporal dementia caused by an R406W mutation in the microtubule associated protein tau (MAPT) gene.
Nimsanor N; Poulsen U; Rasmussen MA; Clausen C; Mau-Holzmann UA; Nielsen JE; Nielsen TT; Hyttel P; Holst B; Schmid B
Stem Cell Res; 2016 Nov; 17(3):576-579. PubMed ID: 27934586
[TBL] [Abstract][Full Text] [Related]
11. Generation of one iPSC line (IMEDEAi006-A) from an early-onset familial Alzheimer's Disease (fAD) patient carrying the E280A mutation in the PSEN1 gene.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Castresana M; Aguillón D; Villegas A; Mastronardi CA; Espinosa LG; Arcos-Burgos M; Del Pozo Á; Herrán E; Gainza E; Isaza-Ruget M; Lopera F; Bachiller D
Stem Cell Res; 2019 May; 37():101440. PubMed ID: 31026686
[TBL] [Abstract][Full Text] [Related]
12. Generation of a human induced pluripotent stem cell (iPSC) line from a patient carrying a P33T mutation in the PDX1 gene.
Wang X; Chen S; Burtscher I; Sterr M; Hieronimus A; Machicao F; Staiger H; Häring HU; Lederer G; Meitinger T; Lickert H
Stem Cell Res; 2016 Sep; 17(2):273-276. PubMed ID: 27879211
[TBL] [Abstract][Full Text] [Related]
13. Establishment of induced pluripotent stem cell line (ZZUi010-A) from an Alzheimer's disease patient carrying an APP gene mutation.
Wang Z; Zhang P; Wang Y; Shi C; Jing N; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
Stem Cell Res; 2017 Dec; 25():213-216. PubMed ID: 29156377
[TBL] [Abstract][Full Text] [Related]
14. Generation of an integration-free iPSC line, ICCSICi006-A, derived from a male Alzheimer's disease patient carrying the PSEN1-G206D mutation.
Díaz-Guerra E; Oria-Muriel MA; Moreno-Jiménez EP; de Rojasb I; Rodríguez C; Rodríguez-Traver E; Orera M; Hernándezb I; Ruizb A; Vicario C
Stem Cell Res; 2019 Oct; 40():101574. PubMed ID: 31627126
[TBL] [Abstract][Full Text] [Related]
15. Generation of induced pluripotent stem cells (IRMBi001-A) from an Alzheimer's disease patient carrying a G217D mutation in the PSEN1 gene.
Auboyer L; Monzo C; Wallon D; Rovelet-Lecrux A; Gabelle A; Gazagne I; Cacheux V; Lehmann S; Crozet C
Stem Cell Res; 2019 Jan; 34():101381. PubMed ID: 30677723
[TBL] [Abstract][Full Text] [Related]
16. Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H271.
Marthaler AG; Schmid B; Tubsuwan A; Poulsen UB; Engelbrecht AF; Mau-Holzmann UA; Hyttel P; Nielsen JE; Nielsen TT; Holst B
Stem Cell Res; 2016 Jan; 16(1):180-3. PubMed ID: 27345809
[TBL] [Abstract][Full Text] [Related]
17. Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H196.
Marthaler AG; Schmid B; Tubsuwan A; Poulsen UB; Engelbrecht AF; Mau-Holzmann UA; Hyttel P; Nielsen JE; Nielsen TT; Holst B
Stem Cell Res; 2016 Jan; 16(1):162-5. PubMed ID: 27345804
[TBL] [Abstract][Full Text] [Related]
18. Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H266.
Marthaler AG; Tubsuwan A; Schmid B; Poulsen UB; Engelbrecht AF; Mau-Holzmann UA; Hyttel P; Nielsen TT; Nielsen JE; Holst B
Stem Cell Res; 2016 Jan; 16(1):202-5. PubMed ID: 27345815
[TBL] [Abstract][Full Text] [Related]
19. Creating a patient carried Men1 gene point mutation on wild type iPSCs locus mediated by CRISPR/Cas9 and ssODN.
Guo D; Liu H; Gao G; Liu Y; Zhuang Y; Yang F; Wang K; Zhou T; Qin D; Hong L; Li J; Xu K; Li YX
Stem Cell Res; 2017 Jan; 18():67-69. PubMed ID: 28395809
[TBL] [Abstract][Full Text] [Related]
20. Generation of an isogenic, gene-corrected iPSC line from a symptomatic 57-year-old female patient with frontotemporal dementia caused by a P301L mutation in the microtubule associated protein tau (MAPT) gene.
Nimsanor N; Kitiyanant N; Poulsen U; Rasmussen MA; Clausen C; Mau-Holzmann UA; Nielsen JE; Nielsen TT; Hyttel P; Holst B; Schmid B
Stem Cell Res; 2016 Nov; 17(3):556-559. PubMed ID: 27789409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]